Modulatory Effects of Antibody Replacement Therapy to Innate and Adaptive Immune Cells.

about

Modulatory Effects of Antibody Replacement Therapy to Innate and Adaptive Immune Cells.

Item

http://www.wikidata.org/entity/Q38697505

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Modulatory Effects of Antibody Replacement Therapy to Innate and Adaptive Immune Cells.

@en

type

Item

label

Modulatory Effects of Antibody Replacement Therapy to Innate and Adaptive Immune Cells.

@en

prefLabel

Modulatory Effects of Antibody Replacement Therapy to Innate and Adaptive Immune Cells.

@en

P1476

Modulatory Effects of Antibody Replacement Therapy to Innate and Adaptive Immune Cells

@en

P2093

Milica Mitrevski

http://www.w3.org/2001/XMLSchema#string

P2860

International Consensus Document (ICON): Common Variable Immunodeficiency Disorders

Blood Monocytes and Their Subsets: Established Features and Open Questions

Manufacture of immunoglobulin products for patients with primary antibody deficiencies - the effect of processing conditions on product safety and efficacy

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

A differential concentration-dependent effect of IVIg on neutrophil functions: relevance for anti-microbial and anti-inflammatory mechanisms.

Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europe

A decreased frequency of regulatory T cells in patients with common variable immunodeficiency

Toll-like receptor 7 and 9 defects in common variable immunodeficiency.

IVIg immune reconstitution treatment alleviates the state of persistent immune activation and suppressed CD4 T cell counts in CVID.

The lack of BTK does not impair monocytes and polymorphonuclear cells functions in X-linked agammaglobulinemia under treatment with intravenous immunoglobulin replacement

P304

697

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2017.00697

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Isabella Quinti

P577

2017-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28670314

http://www.w3.org/2001/XMLSchema#string

P932

5472665

http://www.w3.org/2001/XMLSchema#string